Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Assets Average (2011 - 2026)

Insmed (INSM) posted Assets Average of $2.1 billion for Q2 2026, down 3.73% on a QoQ basis from $2.2 billion in Q1 2026, and down 2.43% year-over-year from $2.1 billion in Q2 2025.

Analysis

Insmed (INSM) Assets Average (2011 - 2026) Analysis & Trends

Insmed has reported Assets Average for 16 years, with the latest figure at $2.1 billion in Q2 2026.

  • On a quarterly basis, Assets Average fell 2.43% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 2.43% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 27.86% from the prior year.
  • Assets Average was $2.1 billion for Q2 2026 at Insmed, down from $2.2 billion in the prior quarter.
  • The five-year high for Assets Average was $2.4 billion in Q3 2025, with the low at $1.0 billion in Q3 2022.
  • Average Assets Average over 5 years is $1.7 billion, with a median of $1.5 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Assets Average surged 61.02% in 2022, then dropped 21.59% in 2024.
  • Over 5 years, Assets Average stood at $1.3 billion in 2022, then grew by 0.13% to $1.3 billion in 2023, then jumped by 53.62% to $2.0 billion in 2024, then rose by 13.42% to $2.3 billion in 2025, then declined by 9.66% to $2.1 billion in 2026.
  • The last three Assets Average figures came in at $2.1 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 5.34 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 30.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 2.09 Bn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 24.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.09 Bn
Mar 31, 2026 2.17 Bn
Dec 31, 2025 2.31 Bn
Sep 30, 2025 2.42 Bn
Jun 30, 2025 2.14 Bn
Mar 31, 2025 1.91 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 1.93 Bn
Jun 30, 2024 1.48 Bn
Mar 31, 2024 1.24 Bn
Dec 31, 2023 1.33 Bn
Sep 30, 2023 1.38 Bn
Jun 30, 2023 1.48 Bn
Mar 31, 2023 1.59 Bn
Dec 31, 2022 1.33 Bn
Sep 30, 2022 1.02 Bn
Jun 30, 2022 1.10 Bn
Mar 31, 2022 1.20 Bn
Dec 31, 2021 1.28 Bn
Sep 30, 2021 1.27 Bn